LATIN T1D (NN9211)

:Type 1 diabetes
:Phase 3

Liraglutide, a once-daily human GLP-1 analogue, intended to offer clinical benefits as adjunct therapy to insulin.

Company announcements
No company announcements matching the search criteria
 

Press releases
No press releases matching the search criteria
 

Scientific abstracts

No scientific abstracts matching the search criteria


You can search for more clinical trials on http://clinicaltrials.gov
  •